Pharmacological inhibition (Nonactin) and genetic silencing of HSPD1 suppressed PCa proliferation, migration, and xenograft growth, while overexpression exacerbated malignant phenotypes. This evidence concerns the gene HSPD1 and posterior cortical atrophy.